Business Insights has just published the report “Generics Launch Strategies in the EU”. At a time of when the ongoing consolidation of the generics industry and the entry of major pharma companies in the generics space are changing the competitive landscape, the report highlights the need for effective strategies for the introduction of new generics products.
The report also shines a light on the key issues that influence the options for successfully launching new generics products in Europe, including the constraints on the freedom to operate in seeking approval of new generics, and the markedly different reimbursement and market environments. The report also assesses the major players, and identifies opportunities for generics and biosimilar products.
The full-text of the report is available on the web to members of the IESE community.